Lockheed Martin 2024 Guidance Looks Conservative

/ / Industrials /

Lockheed Martin appears to be taking aim at lower targets for the coming year. Vertical Research analysts Robert Stallard and Karl Oehlschlaeger say in a research note that the company’s fiscal 2024 guidance looks cautious, with earnings per share forecasts below consensus estimates. They say Lockheed Martin is likely to face similar headwinds to 2023, including delays in F-35 deliveries and lower margins in its Missiles and Fire Control segment. Despite expectations for strong bookings in the next year, the analysts say there’s not much to get too excited about with the stock. They keep their hold rating. Shares fall 4.9% to $436.17.

Lockheed Martin 2024 Guidance Looks Conservative Read Post »

CFRA Keeps Hold Opinion On Shares Of United Airlines Holdings, Inc.

/ / Consumer Discretionary /

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target of $46, down $1, is 4.3x our 2025 EPS view (starting at $10.69; 2024’s cut to $9.08), below UAL’s 2018-2019 historical forward average of 8.4x. We think a discount is merited due to UAL having to ground its 737 MAX 9 aircraft, reducing its total capacity by 8% and causing unit costs to rise. Q4 EPS of $2.00 vs. $2.46 beat consensus by $0.30. Q4 passenger revenues grew 9% Y/Y due to its int’l segment (+18%), while capacity increased 15% Y/Y. For 2024, we believe that UAL could face headwinds with rising unit costs (aside from the 737 MAX 9 groundings) due to new labor agreements, while delays in new aircraft deliveries are hindering UAL from retiring older aircraft and causing maintenance costs to

CFRA Keeps Hold Opinion On Shares Of United Airlines Holdings, Inc. Read Post »

United Airlines Holdings, Inc. (UAL) Q4 2023 Earnings Call Transcript Summary

/ / Consumer Discretionary /

The following is a summary of the United Airlines Holdings, Inc. (UAL) Q4 2023 Earnings Call Transcript: Financial Performance: United Airlines’ q4 total revenue increased by 9.9% due to a 14.7% increase in capacity. Pretax income of $4.3 billion in 2023, an improvement of over $3.2 billion compared to 2022. Earnings per share for the year were reported at $10.05, within the initial guidance range and ahead of consensus expectations. The fourth quarter of the fiscal year saw a pretax income of $845 million and earnings per share of $2, which was above the guided range. The reported CASM-ex (cost-per-available-seat-mile) for the fourth quarter increased by 4.9%. The company maintained their net debt to EBITDAR ratio within its target of less than 3 times. However, United Airlines anticipates a loss per share between $0.35 and $0.85 for the first quarter of 2024. Business Progress: Strides made in both domestic and

United Airlines Holdings, Inc. (UAL) Q4 2023 Earnings Call Transcript Summary Read Post »

Microsoft (NASDAQ:MSFT) Stock Analyst Ratings

/ / Technology /

Microsoft (NASDAQ:MSFT) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/23/2024 50.83% Truist Securities → $600 Reiterates Buy → Buy 01/18/2024 18.4% Exane BNP Paribas → $471 Upgrades Neutral → Outperform 01/12/2024 14.38% Piper Sandler → $455 Reiterates Overweight → Overweight 01/09/2024 5.58% BMO Capital $400 → $420 Maintains Outperform 01/02/2024 14.38% Piper Sandler $425 → $455 Maintains Overweight 12/28/2023 13.12% Wedbush $425 → $450 Maintains Outperform 12/15/2023 13.12% Mizuho $420 → $450 Maintains Buy 12/13/2023 50.83% Truist Securities → $600 Initiates Coverage On → Buy 12/05/2023 8.09% Argus Research $390 → $430 Maintains Buy 12/05/2023 17.14% China Renaissance → $466 Initiates Coverage On → Buy 11/29/2023 19.4% Tigress Financial $433 → $475 Maintains Buy 11/24/2023 5.58% Mizuho $420 → $420 Reiterates Buy → Buy 11/24/2023 -1.96% RBC Capital $390 → $390 Reiterates Outperform → Outperform 11/22/2023 6.83% Wedbush → $425 Reiterates

Microsoft (NASDAQ:MSFT) Stock Analyst Ratings Read Post »

Salesforce (NYSE:CRM) Stock Analyst Ratings

/ / Technology /

Salesforce (NYSE:CRM) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/23/2024 12.1% Baird $300 → $310 Maintains Outperform 01/22/2024 5.95% JMP Securities → $293 Reiterates Market Outperform → Market Outperform 01/11/2024 8.48% Baird $240 → $300 Upgrades Neutral → Outperform 01/02/2024 3.06% Piper Sandler $266 → $285 Maintains Neutral 12/21/2023 26.56% Morgan Stanley $290 → $350 Upgrades Equal-Weight → Overweight 12/20/2023 1.25% Wells Fargo → $280 Downgrades Overweight → Equal-Weight 12/18/2023 13.9% Wolfe Research → $315 Upgrades Peer Perform → Outperform 12/01/2023 4.86% Argus Research $275 → $290 Maintains Buy 11/30/2023 4.86% Evercore ISI Group $275 → $290 Maintains Outperform 11/30/2023 8.48% Raymond James $280 → $300 Maintains Strong Buy 11/30/2023 8.48% Stifel $275 → $300 Maintains Buy 11/30/2023 -0.56% Truist Securities → $275 Reiterates Buy → Buy 11/30/2023 -5.98% JP Morgan $240 → $260 Maintains Overweight 11/30/2023 5.95% JMP Securities $275

Salesforce (NYSE:CRM) Stock Analyst Ratings Read Post »

Intuitive Surgical Stock Performance Depends on Scope of Next Generation Robot, UBS Says

/ / Health Care /

Intuitive Surgical’s (ISRG) stock price seemingly accounts for the expected launch of its next generation robot, but questions remain whether the new product would help the company achieve its growth metrics, UBS said in a note emailed Tuesday. The company is expected to reveal details about its latest robot at the upcoming Society of American Gastrointestinal and Endoscopic Surgeon, or SAGES, meeting in April. The key to Intuitive Surgical’s shares over the next 12 months will be determined by whether the product can accelerate the company’s procedure volume growth in 2025 and beyond and meaningfully increase the total addressable market, the firm noted. UBS maintained its neutral rating on the company’s stock with a price target of $385.

Intuitive Surgical Stock Performance Depends on Scope of Next Generation Robot, UBS Says Read Post »

Lockheed Martin Corporation (LMT) Q4 2023 Earnings Call Transcript Summary

/ / Industrials /

The following is a summary of the Lockheed Martin Corporation (LMT) Q4 2023 Earnings Call Transcript: Financial Performance: Lockheed Martin reported strong sales that matched the previous year’s Q4 results, exceeding expectations by $1 billion and marking a 2.5% growth rate for the full year. The firm reported a 2% annual growth in GAAP EPS, with an adjusted EPS of $27.82. The overall segment operating profit fell by 1% compared to the previous year, despite the increased sales volume. For the full year, the company returned $3.8 billion in dividends and share repurchases, culminating in returns of over $9 billion. Lockheed Martin predicts its 2024 sales to be between $68.5 billion and $70 billion, with expected free cash flow in the region of $6 billion and $6.3 billion. Business Progress: Lockheed Martin reported a surge in demand that resulted in a backlog increase of 7% to a record of $161

Lockheed Martin Corporation (LMT) Q4 2023 Earnings Call Transcript Summary Read Post »

Texas Instruments Incorporated (TI) Reports Q4 2023 and 2023 Financial Results and Shareholder Returns

/ / Technology /

Texas Instruments Incorporated (TI) reports Q4 2023 and 2023 financial results and shareholder returns Conference call on TI website at 3:30 p.m. Central time today PR Newswire DALLAS, Jan. 23, 2024 DALLAS, Jan. 23, 2024 /PRNewswire/ — Texas Instruments Incorporated (TI) (Nasdaq: TXN) today reported fourth quarter revenue of $4.08 billion, net income of $1.37 billion and earnings per share of $1.49. Earnings per share included a 3-cent benefit that was not in the company’s original guidance. Regarding the company’s performance and returns to shareholders, Haviv Ilan, TI’s president and CEO, made the following comments: — “Revenue decreased 10% sequentially and 13% from the same quarter a year ago. During the quarter we experienced increasing weakness across industrial and a sequential decline in automotive. — “Our cash flow from operations of $6.4 billion for the trailing 12 months again underscored the strength of our business model, the quality of our

Texas Instruments Incorporated (TI) Reports Q4 2023 and 2023 Financial Results and Shareholder Returns Read Post »

Texas Instruments Guides For Q1 EPS of $0.96-$1.16 on Revenue of $3.45-$3.75 Billion, Vs CIQ Analyst Consensus of $1.44/Share on Revenue of $4.05 Billion

/ / Technology /

Texas Instruments Guides For Q1 EPS of $0.96-$1.16 on Revenue of $3.45-$3.75 Billion, Vs CIQ Analyst Consensus of $1.44/Share on Revenue of $4.05 Billion.

Texas Instruments Guides For Q1 EPS of $0.96-$1.16 on Revenue of $3.45-$3.75 Billion, Vs CIQ Analyst Consensus of $1.44/Share on Revenue of $4.05 Billion Read Post »

Intuitive Surgical Q4 EPS $1.60 Beats $1.48 Estimate, Sales $1.93B Beat $1.87B Estimate

/ / Health Care /

Intuitive Surgical (NASDAQ:ISRG) reported quarterly earnings of $1.60 per share which beat the analyst consensus estimate of $1.48 by 8.11 percent. This is a 30.08 percent increase over earnings of $1.23 per share from the same period last year. The company reported quarterly sales of $1.93 billion which beat the analyst consensus estimate of $1.87 billion by 3.12 percent. This is a 16.51 percent increase over sales of $1.66 billion the same period last year.

Intuitive Surgical Q4 EPS $1.60 Beats $1.48 Estimate, Sales $1.93B Beat $1.87B Estimate Read Post »

Intuitive Surgical Announces Fourth Quarter Earnings

/ / Health Care /

Intuitive Announces Fourth Quarter Earnings Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) — Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2023. Q4 Highlights   — Worldwide da Vinci procedures grew approximately 21% compared with the      fourth quarter of 2022.   — The Company placed 415 da Vinci surgical systems, compared with 369 in      the fourth quarter of 2022.   — The Company grew its da Vinci surgical system installed base to 8,606      systems as of December 31, 2023, an increase of 14% compared with 7,544      as of the end of the fourth quarter of 2022.   — Fourth quarter 2023 revenue of $1.93 billion increased 17% compared with      $1.66 billion in the fourth quarter of 2022.   — Fourth

Intuitive Surgical Announces Fourth Quarter Earnings Read Post »

Scroll to Top